Skip to main content
main-content

23-05-2019 | Chronic obstructive pulmonary disease | Video

ATS 2019: Eosinophil-guided strategy reduces corticosteroid use in hospitalised COPD patients

Pradeesh Sivapalan and Jens-Ulrik Jensen talk us through CORTICO-COP, a randomised trial indicating that eosinophil-guided therapy is noninferior to standard care for the treatment of acute chronic obstructive pulmonary disease exacerbations, and reduces the duration of corticosteroid exposure (6:47).

Funding for independent interviews at ATS 2019 was provided by F.Hoffmann-La Roche Ltd, Basel, Switzerland.